FindMyKOL
Clinical trialNCT07567794RecruitingObservational

GBPDC: Gut-Brain in PD Consortium Master Protocol

SponsorDuke UniversityEnrollment250Gut MicrobiomeGut MicrobiotaPARKINSON DISEASE (Disorder)Parkinson Disease (PD)Prodromal Parkinsons Disease
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this research study is to identify the role that the gut-brain axis, the group of nerves that connect the brain and gut, plays in Parkinson's disease (PD). The National Institute of Diabetes and Digestive and Kidney Diseases is sponsoring this research study. During this study, specific groups of participants, also known as "cohorts", will be identified based on the severity of their PD. There will also be a cohort enrolling participants who do not have Parkinson's and a cohort enrolling participants that are at risk for developing PD. Each of these cohorts will be compared to the others to assess the differences in the gut-brain connection. Participants in this study will: * meet with a medical provider * answer questionnaires * give samples of blood, stool, and saliva * have X-rays taken while swallowing different foods (swallowing study) * have X-rays taken to see how long it takes markers to move through their colon (colon transit study) * have a flexible sigmoidoscopy, where a doctor looks inside the lower part of the colon and takes small tissue samples (biopsies) from the mucosa (lining) * have samples taken of their skin * have an anorectal manometry and a balloon expulsion test, where a small tube and balloon are placed in the rectum to measure muscle function. Participation in the study will last up to 24 months (2 years).

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Stanford University

    Stanford, California, United States

    Kathleen L Poston, MD, MSLaren S Beckers, MD
    Recruiting
  • Rush University

    Chicago, Illinois, United States

    Ali Keshavarzian, MDChristopher Goetz, MD
    Recruiting
  • University of Chicago

    Chicago, Illinois, United States

    Eugene Chang, MDTao Xie, MD, PhD
    Not, yet, recruiting
  • Massachusetts General Hospital

    Boston, Massachusetts, United States

    Aleksander Videnovic, MD
    Not, yet, recruiting
  • Mayo Clinic

    Rochester, Minnesota, United States

    Adil Bharucha, MBBS, MDRodolfo Savica, MD, PhD
    Recruiting
  • Columbia University

    New York, New York, United States

    Braden Kuo, MD
    Not, yet, recruiting
  • Medical University of South Carolina

    Charleston, South Carolina, United States

    Not, yet, recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
3 Jul 2026
Primary completion
31 Dec 2028
Completion
31 Dec 2028
Last update posted
21 Aug 2026
Registered enrollment
250
Registry id
NCT07567794

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.